Vicplas International Ltd

S$0.06As of Sun 8 Nov 2026, 12:00 UTC
SGX:569Healthcare
Country Singapore
PE (Fwd) •••
TSR 10Y CAGR (2.84%)
Div yield —
ROE (7.39%)
Medical Devices
Beta (5Y) 0.18
PE TTM —
TSR TTM (33.68%)
Mkt cap S$32.20M
ROIC (1.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0708
12.43%
1.80%
Hold 8|6|7|0|11
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
18.67%
25.86%
15.52%
24.42%
Revenue$M
4.020
4.099
4.097
4.079
7.34%
11.55%
8.04%
5.41%
Peers (US$25.11M)
Cap (US$)
PE
24.91M
—
Capital
TTM
5Y
10Y
Leveragex
0.777
0.057
0.058
EBIT/Intx
1.536
0.347
0.324
Own earn%
86.13
(84.96)
(86.93)
Sh yield%
11.13
51.99
48.95
Owners
Insiders/Inst%
13.98
53.64
Short interest%
2.12
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
23–31
$1 testx
−0.1
Incr. ROIC%
1